A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced SarcomaCiara M. Kelly, Sandra P. D’Angelo, Li‐Xuan Qin et al.|Clinical Cancer Research|2023Cited by 71
Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 CasesEdmund K. Bartlett, Charlotte E. Ariyan|Frontiers in Oncology|2021Cited by 9
Data from A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced SarcomaCiara M. Kelly, Sandra P. D’Angelo, Li‐Xuan Qin et al.|Unknown|2023Cited by 1
1527MO Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockadeNicholas D. Klemen, Sandra P. D’Angelo, Edmund K. Bartlett et al.|Annals of Oncology|2021Cited by 1
Supplementary Table from Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced SarcomaNicholas D. Klemen, Sandra P. D’Angelo, Sinchun Hwang et al.|Unknown|2023Cited by 0